Allianz Asset Management GmbH Lowers Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Allianz Asset Management GmbH significantly reduced its stake in Option Care Health, selling 36,180 shares, representing an 82.8% decrease in its holdings during the first quarter.
• Several institutional investors, including Bessemer Group Inc. and Farther Finance Advisors LLC, increased their stakes in Option Care Health, with holdings now making up 98.05% of the company's stock.
• Analysts have a consensus target price of $35.75 for Option Care Health, with an average rating of "Moderate Buy," while the stock is currently trading at around $28.26.

Allianz Asset Management GmbH reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 82.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,500 shares of the company's stock after selling 36,180 shares during the period. Allianz Asset Management GmbH's holdings in Option Care Health were worth $262,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC increased its stake in Option Care Health by 6,525,926.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after buying an additional 1,500,963 shares during the last quarter. Voloridge Investment Management LLC bought a new position in shares of Option Care Health in the fourth quarter worth approximately $27,428,000. Freestone Grove Partners LP purchased a new position in shares of Option Care Health during the fourth quarter worth approximately $17,487,000. Dimensional Fund Advisors LP grew its stake in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the last quarter. Finally, Alyeska Investment Group L.P. raised its holdings in shares of Option Care Health by 159.0% during the fourth quarter. Alyeska Investment Group L.P. now owns 732,948 shares of the company's stock valued at $17,004,000 after acquiring an additional 450,000 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities boosted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Barrington Research restated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Price Performance

Shares of Option Care Health stock traded down $0.20 on Thursday, hitting $27.71. 629,777 shares of the company traded hands, compared to its average volume of 1,852,969. The company has a market cap of $4.50 billion, a P/E ratio of 22.07, a P/E/G ratio of 1.78 and a beta of 0.79. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The firm's 50-day simple moving average is $30.82 and its 200 day simple moving average is $31.94.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the company earned $0.30 earnings per share. The company's revenue was up 15.4% on a year-over-year basis. Analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.